REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/17/2025
Back to search
Official data from USPTO
RUBIUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
03/17/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/11/2017
Registration date
03/17/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2020
Last transaction
03/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/15/2019
First use in commerce
10/15/2019
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
CLYBURN, DIONNE
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Rubius Therapeutics, Inc.
Representatives
CHRISTINA M. LICURSI, ESQ. WOLF GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditionscancerinflammatory diseases and disordersautoimmune diseases and disordersmetabolic diseases and disordersgenetic diseases and disordersinfectious diseases and disorderscardiovascular diseases and disordersother diseases and disorders; pharmaceutical preparations of cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditionscancerinflammatory diseases and disordersautoimmune diseases and disordersmetabolic diseases and disordersgenetic diseases and disordersinfectious diseases and disorderscardiovascular diseases and disordersother diseases and disordersneurological diseases and disordershematological diseases and disordersdermatological diseases and disordersophthalmological diseases and disordersgastrointestinal diseases and disordersgenitourinary diseases and disordersrenal diseases and disordersrespiratory diseases and disordersconnective tissues diseases and disordersenzyme deficiency diseases and disorders
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/12/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/12/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/11/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/11/2020
EX3G
SOU EXTENSION 3 GRANTED
02/11/2020
IUAF
USE AMENDMENT FILED
02/07/2020
EXT3
SOU EXTENSION 3 FILED
02/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
02/07/2020
EISU
TEAS STATEMENT OF USE RECEIVED
02/07/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/14/2019
EX2G
SOU EXTENSION 2 GRANTED
08/13/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/13/2019
EXT2
SOU EXTENSION 2 FILED
08/07/2019
EEXT
SOU TEAS EXTENSION RECEIVED
08/07/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/06/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/06/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/02/2019
EX1G
SOU EXTENSION 1 GRANTED
01/31/2019
EXT1
SOU EXTENSION 1 FILED
01/31/2019
EEXT
SOU TEAS EXTENSION RECEIVED
01/31/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/07/2018
CHPB
POST PUBLICATION AMENDMENT - ENTERED
06/18/2018
APET
ASSIGNED TO PETITION STAFF
06/15/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/12/2018
PUBO
PUBLISHED FOR OPPOSITION
06/12/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/23/2018
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/22/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/02/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/30/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/28/2018
GNRT
NON-FINAL ACTION E-MAILED
01/28/2018
CNRT
NON-FINAL ACTION WRITTEN
01/28/2018
DOCK
ASSIGNED TO EXAMINER
01/20/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2017
Continuous trademark protection
Get notified about every new filing that threatens RUBIUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.